Home » Topics » BioWorld

BioWorld
RSS

NEW COMPANY TARGETS ATHERO

Feb. 5, 1993

NEOPROBE LICENSES CANCER PROBE

Feb. 5, 1993

IMMUNOGEN'S STOCK FALLS AFTER RATING CHANGE

Feb. 5, 1993

OSTEOPOROSIS TRIAL ANALYSIS CONTINUES

Feb. 4, 1993

TRADE GROUP ANNOINTS NEW PRESIDENT

Feb. 4, 1993

HEMACARE UPDATES AIDS TRIAL DATA

Feb. 4, 1993

PRIZM LICENSES DIAGNOSTIC TECHNOLOGY

Feb. 4, 1993

UNITED BIOMEDICAL FILES FOR IPO

Feb. 4, 1993

EUROPEAN PATENT FOR AIDS VACCINE

Feb. 4, 1993

NEW TECHNIQUE TO TARGET CANCER CELLS

Feb. 4, 1993

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...